Rezultati pretrage - Chung‐Pin Li

Detaljiziraj rezultate
  1. 1
    Update on treatment of gastric cancer

    Update on treatment of gastric cancer od Chen‐Yu Kuo, Yee Chao, Chung–Pin Li

    Izdano 2014
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease

    DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease od Mansour A. Parsi, Ang Li, Chung–Pin Li, Michael Goggins

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly

    Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly od Chen-Yi Wu, Y.C. Chou, Nicole Huang, Yiing-Jenq Chou, Hsiao-Yun Hu, Chung-Pin Li

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults

    High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults od Chen‐Yi Wu, Hsiao‐Yun Hu, Yiing‐Jenq Chou, Nicole Huang, Y.C. Chou, Chung–Pin Li

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma

    Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma od Noriyuki Omura, Chung–Pin Li, Ang Li, Seung‐Mo Hong, Kimberly Walter, Antonio Jimeno, Manuel Hidalgo, Michael Goggins

    Izdano 2008
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Pulmonary tuberculosis increases the risk of lung cancer

    Pulmonary tuberculosis increases the risk of lung cancer od Chen‐Yi Wu, Hsiao‐Yun Hu, Christy Pu, Nicole Huang, Hsi‐Che Shen, Chung–Pin Li, Yiing‐Jeng Chou

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma

    Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma od Chi-Shuan Fan, Lili Chen, Tsu‐An Hsu, Chia‐Chi Chen, Kee Voon Chua, Chung–Pin Li, Tze‐Sing Huang

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas

    Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas od Seung‐Mo Hong, David J. Kelly, Margaret Griffith, Noriyuki Omura, Ang Li, Chung–Pin Li, Ralph H. Hruban, Michael Goggins

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study

    How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study od Jack Wang, Chen‐Yi Wu, I-Hsuan Hwang, Chien-Hui Kao, Yi‐Ping Hung, Shinn‐Jang Hwang, Chung–Pin Li

    Izdano 2016
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma

    Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma od Albert Lo, Chung–Pin Li, Elizabeth L. Buza, Rachel Blomberg, Priya Govindaraju, Diana Avery, James Monslow, Michael Hsiao, Ellen Puré

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial

    Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial od Jack Wang, Chen‐Yi Wu, Yi-Cheng Yeh, Yi‐Ming Shyr, Yingying Wu, Chen‐Yu Kuo, Yi‐Ping Hung, Ming‐Huang Chen, Wei‐Ping Lee, Jiing‐Chyuan Luo, Yee Chao, Chung–Pin Li

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy

    Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy od Sheng‐Liang Cheng, H.T. Lee, Chung–Pin Li, Mei‐Wei Lin, Min‐Yuan Chou, Yu‐Ting Yen, T. B. Wu, Yuqing Lian, Yu-Chuan Shih, Chi‐Shiun Chiang, Ting-Wen Chen, Dehui Wan, Yunching Chen

    Izdano 2024
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

    Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study od Yung‐Jue Bang, Chung–Pin Li, Kyung‐Hun Lee, Chang‐Fang Chiu, Joon Oh Park, Yan‐Shen Shan, Jun Suk Kim, Jen‐Shi Chen, Hyun‐Jeong Shim, Kun‐Ming Rau, Hye Jin Choi, Do‐Youn Oh, Bruce Belanger, Li‐Tzong Chen

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies

    Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies od Herbert I. Hurwitz, Eric Van Cutsem, Johanna C. Bendell, Manuel Hidalgo, Chung–Pin Li, Marcelo Garrido Salvo, Teresa Macarulla, Vaibhav Sahai, Ashwin R. Sama, Edward Greeno, Kenneth H. Yu, Chris Verslype, Fitzroy W. Dawkins, Chris Walker, Jason Clark, Eileen M. O’Reilly

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

    Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, rando... od Tanios Bekaii‐Saab, Takuji Okusaka, David Goldstein, Do‐Youn Oh, Makoto Ueno, Tatsuya Ioka, Weijia Fang, Eric Anderson, Marcus Smith Noel, Michele Reni, Hye Jin Choi, Jonathan S. Goldberg, Sang Cheul Oh, Chung–Pin Li, Josep Tabernero, Jian Li, Emma Foos, Cindy Oh, Eric Van Cutsem

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial

    Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: E... od Li‐Tzong Chen, Jens T. Siveke, Andrea Wang‐Gillam, Chung–Pin Li, G. Bodoky, Andrew Dean, Yan‐Shen Shan, Gayle Jameson, Teresa Macarulla, Kyung-Hun Lee, David Cunningham, Jean-Frédéric Blanc, Chang-Fang Chiu, Gilberto Schwartsmann, Fadi S. Braiteh, Khalid Mamlouk, Bruce Belanger, Floris A. de Jong, Richard Hubner

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy

    Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocar... od Jean-Frédéric Blanc, Richard Hubner, Chung‐Pin Li, Andrea Wang‐Gillam, G. Bodoky, Andrew Dean, Yan‐Shen Shan, Gayle Jameson, Teresa Macarulla, Kyung-Hun Lee, David Cunningham, Chang-Fang Chiu, Gilberto Schwartsmann, Fadi Braiteh, Daniel D. Von Hoff, Li‐Tzong Chen, Khalid Mamlouk, Parul Bhargava, F. de Jong, Jens T. Siveke

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study

    Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study od Ian Chau, Joon Oh Park, Baek‐Yeol Ryoo, Chia-Jui Yen, Ronnie T.P. Poon, Davide Pastorelli, Jean-Frédéric Blanc, Masatoshi Kudo, Túlio Pfiffer, Etsuro Hatano, Hyun Cheol Chung, Kateřina Kopečková, Jean-Marc Phélip, Giovanni Brandi, Shinichi Ohkawa, Chung–Pin Li, Takuji Okusaka, Yanzhi Hsu, Paolo Abada, Andrew X. Zhu

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma

    Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma od Ming‐Huang Chen, Kun‐Chun Chiang, Chi‐Tung Cheng, Shih‐Chiang Huang, Yeng-Yang Chen, Tsung-Wen Chen, Ta-Sen Yeh, Yi‐Yin Jan, Hsi-Ming Wang, Jiang-Jie Weng, Peter Mu‐Hsin Chang, Chun‐Yu Liu, Chung–Pin Li, Yee Chao, Ming‐Han Chen, Chi‐Ying F. Huang, Chun‐Nan Yeh

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours

    Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours od Hsi‐Chien Huang, Yun‐Chieh Sung, Chung–Pin Li, Dehui Wan, Po‐Han Chao, Yu‐Ting Tseng, Bo-Wen Liao, Hui‐Teng Cheng, Fu‐Fei Hsu, Chieh‐Cheng Huang, Yi‐Ting Chen, Yuhui Liao, Hsin Tzu Hsieh, Yu‐Chuan Shih, I-Ju Liu, Han‐Chung Wu, Tsai‐Te Lu, Jane Wang, Yunching Chen

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: